paroxysmal nocturnal hemoglobinuria (PNH) | Aplastic Anemia & MDS International Foundation Return to top.

paroxysmal nocturnal hemoglobinuria (PNH)

Find Out More:

Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria

Author(s): 
Schrezenmeier H, Kulasekararaj A, Mitchell L, de Latour RP, Devos T, Okamoto S, Wells R, Popoff E, Cheung A, Wang A, Tomazos I, Patel Y, Lee JW
Primary Author: 
Schrezenmeier H
Journal Title: 
Annals of Hematology
Original Publication Date: 
Oct 2023

Bone Marrow Disease(s): 

Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia

Author(s): 
Shinn LT, Benitez LL, Perissinotti AJ, Reid JH, Buhlinger KM, van Deventer H, Barth D, Wagner CB, Zacholski K, Desai R, Soule A, Stump SE, Weis TM, Bixby D, Burke P, Pettit K, Marini BL
Primary Author: 
Shinn LT
Journal Title: 
International Journal of Hematology
Original Publication Date: 
Oct 2023

Aplastic Anemia, MDS, and PNH Virtual Support Group -Saturdays- 2023 December

Event Date: 
Sat, 12/16/2023 - 10:30am (EST)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Share with addtoany.com.